Yoshikiyo Ono Selected Research

Yoshikiyo Ono Research Topics

Disease

21	Hyperaldosteronism (Conn Syndrome) 01/2022 - 04/2012
20	Adenoma (Adenomas) 02/2022 - 04/2014
12	Neoplasms (Cancer) 01/2022 - 08/2014
5	Hyperplasia 01/2021 - 05/2015
5	Adrenocortical Adenoma (Disease, Conn's) 11/2020 - 01/2016
3	Adrenocortical Carcinoma 01/2022 - 04/2014
3	Hypertension (High Blood Pressure) 08/2021 - 10/2014
3	Cushing Syndrome 01/2021 - 01/2016
3	Pheochromocytoma 01/2020 - 12/2018
2	Paraganglioma (Paragangliomas) 01/2020 - 12/2018
2	Essential Hypertension 05/2019 - 01/2017
1	Ulcerative Colitis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	Hypercalciuria 06/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2020
1	Metabolic Diseases (Metabolic Disease) 06/2020
1	Osteoporosis 06/2020
1	Hypocalcemia 06/2020
1	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2020
1	Morbid Obesity 11/2019
1	Insulin Resistance 11/2019
1	Obesity 11/2019
1	Craniopharyngioma (Craniopharyngiomas) 11/2019
1	Germinoma 11/2019
1	Combined Pituitary Hormone Deficiency 11/2019
1	Isolated Systolic Hypertension 03/2016
1	Brain Infarction 01/2015
1	Chronic Renal Insufficiency 05/2014

Drug/Important Bio-Agent (IBA)

22	AldosteroneIBA 01/2022 - 04/2014
9	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2022 - 04/2014
7	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2022 - 04/2014
7	EnzymesIBA 01/2022 - 08/2014
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 08/2014
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 04/2012
3	SteroidsIBA 01/2022 - 02/2020
3	Biological ProductsIBA 11/2020 - 01/2018
3	CatecholaminesIBA 01/2020 - 12/2018
3	Oxidoreductases (Dehydrogenase)IBA 01/2016 - 12/2014
2	CholesterolIBA 02/2022 - 01/2022
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 10/2014
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2014
2	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2022 - 01/2016
2	LipidsIBA 11/2020 - 01/2020
2	ReninIBA 01/2017 - 01/2017
2	3 beta-hydroxysteroid dehydrogenase type IIIBA 01/2016 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 12/2014 - 04/2014
1	nasIBA 01/2022
1	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 01/2022
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2022
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Butylated Hydroxyanisole (BHA)IBA 01/2021
1	ElectrolytesIBA 01/2021
1	Dehydroepiandrosterone (DHEA)IBA 11/2020
1	Parathyroid Hormone (Parathormone)IBA 06/2020
1	CalciumIBA 06/2020
1	Vitamin D FDA LinkGeneric 06/2020
1	Estrogens (Estrogen)FDA Link 02/2020
1	AndrogensIBA 02/2020
1	Hormones (Hormone)IBA 02/2020
1	Insulin (Novolin)FDA Link 11/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016
1	Nerve Growth Factor (NGF)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 06/2015
1	18-oxocortisolIBA 05/2015
1	18-hydroxycortisolIBA 05/2015
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2014
1	Monoclonal AntibodiesIBA 12/2014
1	Angiotensin IIIBA 12/2014
1	Calcium Channels (Calcium Channel)IBA 10/2014
1	Mineralocorticoid Receptor AntagonistsIBA 05/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	LuciferasesIBA 04/2014

Therapy/Procedure

6	Adrenalectomy 08/2021 - 05/2014
2	Lasers (Laser) 01/2022 - 01/2015
2	Therapeutics 01/2021 - 01/2016
1	Gastrectomy 11/2019
1	Radiotherapy 11/2019
1	Bariatric Surgery 11/2019
1	Aftercare (After-Treatment) 05/2014